Hofseth BioCare ASA (OSL: HBC)

Market Cap	550.85M
Revenue (ttm)	248.08M
Net Income (ttm)	-133.48M
Shares Out	411.08M
EPS (ttm)	-0.33
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	122,468
Open	1.350
Previous Close	1.350
Day's Range	1.240 - 1.350
52-Week Range	1.200 - 2.820
Beta	0.34
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Hofseth BioCare ASA

Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company’s products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism, and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. The company was incorporated in 200...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Employees: 71
• Stock Exchange: Oslo Børs
• Ticker Symbol: HBC

Financial Performance

In 2023, Hofseth BioCare ASA's revenue was 218.51 million, an increase of 81.42% compared to the previous year's 120.45 million. Losses were -106.68 million, -22.35% less than in 2022.